Google DeepMind’s drug discovery spin-off Isomorphic Labs raises $600mn
Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit, has raised $600mn in its first external funding round, as investors bet on the potential for AI ...
Google embraces health care’s AI agentic era
Developing new therapies: The newest of the bots is TxGemma, a collection of language models aimed at helping pharmaceutical ...
Google-backed AI drug discovery startup raises $600 million
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday.
Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Scientific American10d
Artificial Intelligence is Reshaping Healthcare
Pathology is a field that seems ripe for assistance from recent advances in artificial intelligence. Beck’s company is one of ...
Google DeepMind CEO says his passion for chess led to his career in AI
Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...
The Information12d
Google DeepMind’s Expanding Org
As Google attempts to catch up to OpenAI’s ChatGPT, its DeepMind artificial intelligence unit is in a near constant state of ...